Shares of Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) were up 9.1% on Tuesday . The stock traded as high as GBX 1.80 ($0.02) and last traded at GBX 1.80 ($0.02). Approximately 1,744,599 shares were traded during mid-day trading, an increase of 4% from the average daily volume of 1,670,021 shares. The stock had previously closed at GBX 1.65 ($0.02).
Cizzle Biotechnology Stock Performance
The business has a 50 day moving average price of GBX 1.79 and a 200-day moving average price of GBX 1.84. The company has a market capitalization of £7.29 million, a price-to-earnings ratio of -183.80 and a beta of 0.38.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Featured Stories
- Five stocks we like better than Cizzle Biotechnology
- How to Plot Fibonacci Price Inflection Levels
- Merck: 4 No-Brainer Reasons to Buy This Dip
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- 5 discounted opportunities for dividend growth investors
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
